COSM
Cosmos Health Inc. NASDAQ$0.36
Mkt Cap $10.8M
52w Low $0.28
7.3% of range
52w High $1.32
50d MA $0.35
200d MA $0.62
P/E (TTM)
-0.6x
EV/EBITDA
-1.7x
P/B
0.6x
Debt/Equity
0.6x
ROE
-103.9%
P/FCF
-1.8x
RSI (14)
—
ATR (14)
—
Beta
4.46
50d MA
$0.35
200d MA
$0.62
Avg Volume
885.3K
About
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products tha…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2025 | AMC | -0.01 | -0.17 | -1600.0% | 0.72 | +1.1% | -3.0% | -3.0% | -10.1% | -13.6% | -6.1% | -42.4% | — |
| Aug 18, 2025 | AMC | 0.01 | -0.06 | -700.0% | 0.85 | -1.8% | -2.1% | -8.7% | -10.6% | -0.8% | -3.7% | +9.7% | — |
| May 15, 2025 | AMC | -0.03 | 0.01 | +133.3% | 0.45 | -0.7% | -3.8% | -3.8% | +0.2% | +5.6% | -0.7% | -1.3% | — |
| Apr 15, 2025 | AMC | -0.09 | -0.08 | +11.1% | 0.35 | +2.6% | -0.9% | -3.7% | -8.6% | +3.4% | +14.9% | +28.2% | — |
| Nov 14, 2024 | AMC | -0.11 | -0.45 | -309.1% | 0.65 | -2.0% | -3.5% | +7.2% | +13.3% | +10.3% | +16.4% | +7.2% | — |
| Aug 20, 2024 | AMC | -0.14 | -0.04 | +71.4% | 1.07 | -3.7% | +17.8% | +19.6% | +14.0% | +11.2% | +12.1% | +1.9% | — |
| Aug 6, 2024 | AMC | -0.20 | 0.10 | +150.0% | 1.15 | +1.7% | -6.1% | -2.6% | -6.1% | -6.1% | -4.3% | -7.0% | — |
| Jul 2, 2024 | AMC | -0.14 | -0.04 | +71.4% | 1.01 | +2.0% | -10.9% | +5.9% | +22.8% | +17.8% | +17.8% | +20.8% | — |
| Nov 21, 2023 | AMC | — | -0.09 | — | 1.03 | +0.0% | +0.0% | +5.8% | +2.9% | +3.9% | -1.0% | +36.9% | — |
| Aug 15, 2023 | AMC | — | 0.02 | — | 1.30 | -6.9% | +3.1% | +13.8% | +4.6% | +6.9% | +0.0% | -0.8% | — |
Recent Filings
8-K
Unknown — 8-K Filing
Cosmose Software faces significant uncertainty regarding future performance, as management acknowledges material risks beyond its control could derail guidance, warranting investor caution on earnings forecasts.
Apr 16
NT 10-K
!!! Very High
Unknown — Late Annual Report — Distress Signal
A missed annual report deadline signals potential financial distress or operational chaos at Cosmos Health, likely causing stock delisting risk and investor confidence collapse—sell immediately unless restructuring news emerges.
Apr 1
Data updated apr 25, 2026 2:43am
· Source: massive.com